J. Safra Sarasin Holding’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.8M Sell
206,411
-1,269
-0.6% -$434K 1.04% 23
2026
Q1
$73.1M Sell
207,680
-38,033
-15% -$13.6M 1.25% 19
2025
Q4
$80.4M Sell
245,713
-1,415
-0.6% -$449K 1.31% 17
2025
Q3
$69.7M Buy
247,128
+6,833
+3% +$1.98M 1.13% 22
2025
Q2
$67.1M Sell
240,295
-6,060
-2% -$1.72M 1.16% 24
2025
Q1
$76.8M Buy
246,355
+1,478
+0.6% +$436K 1.39% 17
2024
Q4
$63.8M Sell
244,877
-26,882
-10% -$7.98M 1.08% 28
2024
Q3
$87.6M Buy
271,759
+3,236
+1% +$1.06M 1.52% 13
2024
Q2
$83.9M Buy
+268,523
New +$78.9M 1.53% 9

Other funds holding AMGN

J. Safra Sarasin Holding's AMGN Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Amgen (AMGN) stake by 0.61% in Q2 2026, selling an estimated $434K and leaving 206,411 shares worth $72.8M. The position accounts for 1.04% of the portfolio, ranked #23.

J. Safra Sarasin Holding first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $87.6M in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • J. Safra Sarasin Holding held 206,411 shares of Amgen worth $72.8M as of Q2 2026.
  • J. Safra Sarasin Holding sold 1,269 Amgen shares in Q2 2026, an estimated $434K.
  • Amgen made up 1.04% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #23 holding.
  • J. Safra Sarasin Holding first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • J. Safra Sarasin Holding's Amgen position peaked at $87.6M in Q3 2024.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.